Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Adams sues Perrigo

This article was originally published in The Tan Sheet

Executive Summary

Adams Respiratory Therapeutics filed suit Sept. 27 in U.S. District Court for the District of New Jersey against Perrigo, alleging infringement of Adams' '252 patent for the Mucinex line of extended-release guaifenesin products. The lawsuit responds to the private labeler's filing of a Paragraph IV certification for an ANDA for a 600 mg guaifenesin tablet, equivalent to single-ingredient Mucinex, and initiates a 30-month stay, preventing FDA from approving Perrigo's product unless a court rules against Adams or that period expires (1"The Tan Sheet" Aug. 27, 2007, p. 12)...
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS100942

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel